Stocktoria
IGC Pharma, Inc. IGC
NYSE American · XASE · stock
IGC Pharma, Inc. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 48.7% | 54.5% | 48.5% | 48.9% | 12.6% | 2.8% | 2.6% | 3.7% | 37.6% | — |
| Operating margin | -585.8% | -728.5% | -1270.1% | -3886.1% | -971.5% | -168.6% | -90.8% | -81.6% | -354.0% | -45.6% |
| Net margin | -560.3% | -966.5% | -1263.0% | -3782.4% | -981.2% | -179.6% | -80.1% | -81.4% | -321.7% | -44.1% |
| FCF margin | -386.1% | -396.8% | -807.6% | -1939.0% | -1366.4% | -320.9% | -65.4% | -94.3% | -264.8% | -4.4% |
| Return on assets | -81.4% | -131.3% | -67.0% | -56.0% | -24.6% | -25.2% | -11.9% | -16.5% | -16.5% | -14.9% |
| Return on equity | -112.5% | -177.6% | -77.2% | -62.8% | -26.9% | -27.6% | -12.2% | -22.1% | -25.4% | -20.1% |
| Debt / equity | 0.02× | 0.02× | 0.01× | 0.01× | 0.01× | 0.00× | — | — | 0.06× | 0.06× |
| Current ratio | 1.28 | 1.58 | 3.41 | 6.19 | 9.93 | 9.12 | 30.44 | 1.37 | 2.78 | 1.20 |
Source: SEC EDGAR filings · CIK 0001326205 · US · as of 2025-03-31. facts plus Stocktoria's own computed scores — not investment advice.